Several factors influence whether Ozempic might be appropriate for someone with Crohn's disease: Disease activity : Patients in stable remission may tolerate the medication differently than those with active inflammation Location of disease : Gastric or upper gastrointestinal involvement might be more problematic given Ozempic's effect on gastric emptying Nutritional status : Individuals already struggling with malabsorption or weight loss may be at higher risk Concurrent medications : While no clinically relevant interactions with common oral medications have been established for subcutaneous semaglutide, monitoring may be prudent Additional important cautions with semaglutide include: Risk of worsening diabetic retinopathy, particularly with rapid glycaemic improvement Increased risk of gallbladder disease, especially with substantial weight loss Potential for dehydration leading to renal impairment Increased risk of hypoglycaemia when used with sulfonylureas or insulin The MHRA and EMA have not issued specific warnings regarding Ozempic use in IBD patients beyond the general caution for severe gastrointestinal disease

Disponible en: Administracin de Alimentos y Medicamentos de EE
Multiple Sclerosis: Understanding the Condition Multiple sclerosis (MS) is a chronic, progressive neurological condition affecting the central nervous system, including the brain, spinal cord, and optic nerves
Karolin Kamel A-A
in the genetic disorder Refsum disease, this system is impaired and phytanic acid accumulates in the plasma lipids
Copper and zinc compete for the same intestinal transporters, so sustained daily oral copper exposure can interact with zinc absorption over time